HuGE Literature Finder
Records
1
-
30
| Immunotherapy combined with chemotherapy improved clinical outcomes over bevacizumab combined with chemotherapy as first-line therapy in adenocarcinoma patients. Cancer medicine 2022 Oct . Wang Min, Li Ji, Xu Shuhui, Li Yuying, Li Jiatong, Yu Jinming, Tang Xiaoyong, Zhu H |
| Prognostic impact of tumour mutational burden in resected stage I and II lung adenocarcinomas from a European Thoracic Oncology Platform Lungscape cohort. Lung cancer (Amsterdam, Netherlands) 2022 Oct 174 27-35. Bubendorf Lukas, Zoche Martin, Dafni Urania, Rüschoff Jan Hendrik, Prince Spasenija Savic, Marti Nesa, Stavrou Androniki, Kammler Roswitha, Finn Stephen P, Moch Holger, Peters Solange, Stahel Rolf |
| Next generation sequencing targeted detection of somatic mutations in patients with mucinous adenocarcinoma of the appendix. Annals of diagnostic pathology 2022 Aug 61 152024. Jian Dan, Lu Xianfeng, Wang Dong, Li Mengxia, Yang Yuxin, Chen Qian, Qian Chengyuan, Shao Weikang, Dai Nan, Feng Y |
| Tumor mutational burden and efficacy of chemotherapy in lung cancer. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 2022 Aug . Song Juan, Yan Yu, Chen Cuicui, Li Jiamin, Ding Ning, Xu Nuo, Bao Hairong, Zhang Xin, Hong Qunying, Zhou Jian, Shao Yang W, Song Yuanlin, Tong Lin, Hu J |
| Whole-Exome Sequencing Reveals the Genomic Features of the Micropapillary Component in Ground-Glass Opacities. Cancers 2022 Aug 14 (17): . Meng Fanchen, Zhang Yi, Wang Siwei, Liu Tongyan, Sun Mengting, Zhu Hongyu, Dong Guozhang, Xia Zhijun, You Jing, Kong Xiangru, Wu Jintao, Chen Peng, Yuan Fangwei, Yu Xinyu, Xu Youtao, Xu Lin, Yin Ro |
| Clinicopathologic and genomic features of high-grade pattern and their subclasses in lung adenocarcinoma. Lung cancer (Amsterdam, Netherlands) 2022 Jul 170 176-184. Ahn Bokyung, Yoon Shinkyo, Kim Deokhoon, Chun Sung-Min, Lee Goeun, Kim Hyeong-Ryul, Jin Jang Se, Sang Hwang H |
| Genomic characterization of undifferentiated sarcomatoid carcinoma of the pancreas. Human pathology 2022 Jul . Gkountakos Anastasios, Mafficini Andrea, Lou Emil, Malleo Giuseppe, Salvia Roberto, Calicchia Martina, Silvestris Nicola, Racila Emilian, Amin Khalid, Veronese Nicola, Brunetti Oronzo, Antonini Pietro, Ingravallo Giuseppe, Mattiolo Paola, Saponaro Concetta, Nappo Floriana, Simbolo Michele, Bariani Elena, Lonardi Sara, Fassan Matteo, Milella Michele, Lawlor Rita T, Scarpa Aldo, Luchini Claud |
| Distinct mechanisms of innate and adaptive immune regulation underlie poor oncologic outcomes associated with KRAS-TP53 co-alteration in pancreatic cancer. Oncogene 2022 Jun . Datta Jashodeep, Bianchi Anna, De Castro Silva Iago, Deshpande Nilesh U, Cao Long Long, Mehra Siddharth, Singh Samara, Rafie Christine, Sun Xiaodian, Chen Xi, Dai Xizi, Colaprico Antonio, Sharma Prateek, Dosch Austin R, Pillai Asha, Hosein Peter J, Nagathihalli Nagaraj S, Komanduri Krishna V, Wilson Julie M, Ban Yuguang, Merchant Nipun |
| Gene alternation of cerebrospinal fluid in patients with leptomeningeal metastases of lung adenocarcinoma using next-generation sequencing. BMC cancer 2022 May 22 (1): 580. Yang Hainan, Wen Lei, Pan Yingying, Shan Changguo, Hong Weiping, Wang Hui, Zhou Cheng, Cai Linbo, Zhou Caic |
| Association of recurrent APOBEC3B alterations with the prognosis of gastric-type cervical adenocarcinoma. Gynecologic oncology 2022 Feb . Liao Xin, Xia Xuyang, Su Wei, Yan Huayun, Ma Yingfang, Xu Lian, Luo Han, Liu Wanting, Yin Dandan, Zhang Wei-Han, Chen Hai-Ning, Deng Yiqi, Ren Zhixiang, Yu Zehui, Liao Fei, Chen Keling, Cao Minyuan, Zhang Yiguan, Zhang Wei, Wang Wei, Zhao Jun-Ning, Xu Heng, Shu Ya |
| The genetic landscape of pancreatic head ductal adenocarcinoma in China and prognosis stratification. BMC cancer 2022 Feb 22 (1): 186. Yang Yefan, Ding Ying, Gong Yuxi, Zhao Sha, Li Mingna, Li Xiao, Song Guoxin, Zhai Boya, Liu Jin, Shao Yang, Zhu Liuqing, Pang Jiaohui, Ma Yutong, Ou Qiuxiang, Wu Xue, Zhang Zhiho |
| Genetic alteration and PD-L1 expression profiles of Chinese patients with lung squamous cell carcinoma. Pathology, research and practice 2022 Jan 231 153761. Chen Ying, Kong Wencui, Yu Zongyang, Zhao Zhongqu |
| A novel defined m7G regulator signature to investigate the association between molecular characterization and clinical significance in lung adenocarcinoma. Frontiers in oncology 2022 12 897323. Dong Yi, Li Yingge, Yao Yi, Song Qib |
| A special prognostic indicator: tumor mutation burden combined with immune infiltrates in lung adenocarcinoma with TP53 mutation. Translational cancer research 2022 2 10 (9): 3963-3978. Fu Jing, Li Yaonan, Li Cuidan, Tong Yuyang, Li Mengyuan, Cang Shundo |
| ATM Germline-Mutated Gastroesophageal Junction Adenocarcinomas: Clinical Descriptors, Molecular Characteristics, and Potential Therapeutic Implications. Journal of the National Cancer Institute 2022 1 114 (5): 761-770. El Jabbour Tony, Misyura Maksym, Cowzer Darren, Zimmermann Michal, Rimkunas Victoria, Marra Antonio, Derakhshan Fatemeh, Selenica Pier, Parilla Megan, Setton Jeremy S, Ceyhan-Birsoy Ozge, Kemel Yelena, Catchings Amanda, Ranganathan Megha, Ku Geoffrey Y, Janjigian Yelena Y, Zinda Michael, Koehler Maria, Stadler Zsofia, Shia Jinru, Reis-Filho Jorge S, Mandelker Dia |
| Genetic Alterations Predict Long-Term Survival in Ductal Adenocarcinoma of the Pancreatic Head. Cancers 2022 2 14 (3): . Safi Sami-Alexander, Haeberle Lena, Goering Wolfgang, Keitel Verena, Fluegen Georg, Stoecklein Nikolas, Rehders Alexander, Knoefel Wolfram Trudo, Esposito Ire |
| Integration of Single-Cell RNA Sequencing and Bulk RNA Sequencing Data to Establish and Validate a Prognostic Model for Patients With Lung Adenocarcinoma. Frontiers in genetics 2022 2 13 833797. Jiang Aimin, Wang Jingjing, Liu Na, Zheng Xiaoqiang, Li Yimeng, Ma Yuyan, Zheng Haoran, Chen Xue, Fan Chaoxin, Zhang Rui, Fu Xiao, Yao |
| Pancreatic Cancer with Mutation in BRCA1/2, MLH1, and APC Genes: Phenotype Correlation and Detection of a Novel Germline BRCA2 Mutation. Genes 2022 2 13 (2): . Vietri Maria Teresa, D'Elia Giovanna, Caliendo Gemma, Albanese Luisa, Signoriello Giuseppe, Napoli Claudio, Molinari Anna Mar |
| Rapid recurrence of a ruptured mucinous borderline ovarian tumor harboring K-RAS mutation followed by progression into anaplastic carcinoma with TP53 mutation. Heliyon 2022 10 8 (10): e10877. Yang Yang, Guan Yanxian, Xu Manman, Liu Junx |
| The clinicopathological and molecular characteristics of resected EGFR-mutant lung adenocarcinoma. Cancer medicine 2022 1 11 (5): 1299-1309. Zhou Wensheng, Liu Zhichao, Wang Yanan, Zhang Yanwei, Qian Fangfei, Lu Jun, Wang Huimin, Gu Ping, Hu Minjuan, Chen Ya, Yang Zhengyu, Zhao Ruiying, Lou Yuqing, Han Baohui, Zhang W |
| TTN/TP53 mutation might act as the predictor for chemotherapy response in lung adenocarcinoma and lung squamous carcinoma patients. Translational cancer research 2022 2 10 (3): 1284-1294. Xue Dan, Lin Hongguang, Lin Lan, Wei Qiongying, Yang Sheng, Chen Xiang |
| Yolk Sac Tumor in a Recurrence of Colonic Adenocarcinoma With Shared Mutations in APC and TP53 Genes: A Case Report. International journal of surgical pathology 2022 1 30 (6): 646-651. Otani Tomoyuki, Kanemura Hiroaki, Kimura Masatomo, Mitani Seiichiro, Takeda Masayuki, Matsuki Mitsuru, Matsumura Noriomi, Satou Takao, Nakagawa Kazuhiko, Ito Akihi |
| Clinicopathological features and genomic profiles of hepatoid adenocarcinoma of the lung: Report of four cases. Pathology, research and practice 2021 Nov 229 153652. Sun Hui, Li Xiaoli, Zhang Jianguo, Liu Yif |
| Microsatellite Instability Is Rare in the Admixed Brazilian Population of Non-Small Cell Lung Cancer: A Cohort of 526 Cases. Pathobiology : journal of immunopathology, molecular and cellular biology 2021 Nov 1-6. De Marchi Pedro, Berardinelli Gustavo Noriz, Cavagna Rodrigo de Oliveira, Pinto Icaro Alves, da Silva Flavio Augusto Ferreira, Duval da Silva Vinicius, Santana Iara Viana Vidigal, da Silva Eduardo Caetano Albino, Ferro Leal Leticia, Reis Rui Manu |
| Mutational status of main driver genes influences the prognosis of stage I-III lung adenocarcinoma patients underwent radical surgery. Translational cancer research 2021 Jul 10 (7): 3286-3298. Liao Hongliang, Luo Xiaoyan, Liang Yaqin, Wan Renping, Xu Me |
| Retrospective analysis of eleven gene mutations, PD-L1 expression and clinicopathological characteristics in non-small cell lung cancer patients. Asian journal of surgery 2021 Jul . Liu Yanqing, Wu Aihua, Li Xinjian, Wang Shanshan, Fang Shuyu, Mo Yij |
| An aging-related signature predicts favorable outcome and immunogenicity in lung adenocarcinoma. Cancer science 2021 12 113 (3): 891-903. Zhang Wenjing, Li Yuting, Lyu Juncheng, Shi Fuyan, Kong Yujia, Sheng Chao, Wang Suzhen, Wang Qingh |
| Genetic Alteration Profiling of Chinese Lung Adenocarcinoma and Its Effect on Targeted Therapy Efficacy. Frontiers in oncology 2021 12 11 726547. Liu Jie, Xu Wang-Yang, Ye Maosong, Liu Zilong, Li Ch |
| Genomic Profiling of Chinese Cervical Cancer Patients Reveals Prevalence of DNA Damage Repair Gene Alterations and Related Hypoxia Feature. Frontiers in oncology 2021 11 792003. Wen Hao, Guo Qin-Hao, Zhou Xiao-Lan, Wu Xiao-Hua, Li J |
| Low-Cost Genetic and Clinical Predictors of Response and Toxicity of Platinum-Based Chemotherapy in Advanced Non-Small Cell Lung Cancer. Dose-response : a publication of International Hormesis Society 0 20 (2): 15593258221111666. Spasic Jelena, Cavic Milena, Stanic Nemanja, Zaric Bojan, Kovacevic Tomi, Radosavljevic Davorin, Nagorni-Obradovic Ljudmi |
- Page last reviewed:Jul 25, 2022
- Page last updated:Jan 27, 2023
- Content source: